Posts

📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kids

i4kids Closing Event 2022

On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven…
Biotech New Frontiers Award 2022Gate2Brain

G2B awarded with Biotech New Frontiers 2022

Gate2Brain award with Biotech New Frontiers 2022 Gate2Brain attended the 5th Congress of Medical Biotechnology…
VII SEQT Summer School “Medicinal Chemistry and Chemical Biology in Drug DiscoveryGate2Brain

Gate2Brain at the VII SEQT Summer School

Our CEO, Meritxell Teixidó, participated as a speaker to the VII SEQT Summer School “Medicinal Chemistry…
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.

Gate2Brain will be attending The Investment Readiness Series

On the 4th of July, Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series,…

Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck

Meritxell Teixidó: “Una gran quantitat de fàrmacs no arriben al cervell, i la tecnologia de Gate2Brain…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social